The unexpected side effects and safety of therapeutic monoclonal antibodies.

Abstract

Monoclonal antibodies (MAbs) have ushered in a new era of targeted therapy, particularly in the fields of immunotherapy and oncology. MAbs have been developed from murine antibodies to fully human antibodies, with significant improvements in immunogenicity and safety. Nevertheless, the safety of these agents is being paid close attention with relative side… (More)
DOI: 10.1358/dot.2014.50.1.2076506

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics